ApoB/ApoA1 ratio and subclinical atherosclerosis

International Angiology

Volumn 27, Issue 1, 2008, Pages 74-80

  Panayiotou, Andrie ^a,h   Griffin, M ^b,c   Georgiou, N ^c   Bond, D ^b,c   Tyllis, T ^c   Tziakouri Shiakalli, C ^d   Fessas, C ^e   Nicolaides, A ^a,b,c,f,g  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b Vascular Screening and Diagnostic Centre   (United Kingdom)

^c Vascular Screening and Diagnostic Centre Nicosia   (Cyprus)

^d NICOSIA GENERAL HOSPITAL   (Cyprus)

^e Cyprus Heart Foundation   (Cyprus)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^h NONE   (Cyprus)

Author keywords

Apolipoproteins; Atherosclerosis; Cardiovascular diseases

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; HISTORY OF MEDICINE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RANDOMIZATION; RISK FACTOR;

AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL; FEMALE; FEMORAL ARTERY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUNICA INTIMA; TUNICA MEDIA;

EID: 42149184153     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practise: recommendations of the second joint task force of European and other societies on coronary prevention. Atherosclerosis 1998;140:199-270.
2. Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic HyperapoB: The unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001;135:447-59.
3. Sattar N, Williams K, Sniderman AD, D' Agostino R, Haffner SM. Comparison of the associations of apolipoprotein B and Non-High-Density lipoprotein cholesterol with other cardiovascular risk factors in patients with the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 2004;110:2687-93.
4. Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003;361:777-80.
5. Williams K, Sniderman AD, Sattar N, D'Agostino R, Wagenknecht LE, Haffner SM. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003;108:2312-6.
6. Wallenfeldt K, Bokemark L, Wikstrand J, Hulthe J, Fagerberg B. Apolipoprotein B/Apolipoprotein A-I in relation to the Metabolic Syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 2004;35:2248-52.
7. Ogata T, Yasaka M, Yamagishi M, Seguchi O, Nagatsuka K, Minematsu K. Atherosclerosis found on carotid ultrasonography is associated with atherosclerosis on coronary intravascular ultrasonography. J Ultrasound Med 2005;24:469-74.
8. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. A tool for targeting and evaluating vascular preventive therapy. Stroke 2002;33:2916-22.
9. Spence JD. Technology insight: ultrasound measurement of carotid plaque-patient management, genetic research and therapy evaluation. Nat Clin Pract Neurol 2006;2:611-9.
10. Brook RD, Bard RL, Patel S, Rubenfire M, Clarke NS, Kazerooni EA et al. Arterioscler Thromb Vasc Biol 2006;26:656-62.
11. Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997;80:1429-33.
12. Schmidt C, Fagerberg B, Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis 2005;181:125-30.
13. Kuller LH, Arnold AM, Psaty BM, Robbins JA, O'Leary DH, Tracy RP. 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Arch Intern Med 2006;166: 71-8.
14. Iglesias del Sol A, Moons KGM, Hollander M, Hofman A, Koudstaal PJ, Grobbee DE et al. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke 2001;32:1532-8.
15. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
16. Polak JF, Shemanski L, O'Leary DH, Lefkowitz D, Price TR, Savage PJ et al. Hypoechoic plaque at US of the carotid artery: An independent risk factor for incident stroke in adults aged 65 years or older. Radiology 1998;208:649-54.
17. Mathiesen E.B, Bonaa KH, Joakimsen O. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: The Tromso study. Stroke 2001;32:1960-5.
18. Gronholdt M-L, Nordesrgaard BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001;104:68-73.
19. Al-Shali K, House AA, Hanley AJG, Khan HMR, Harris SB, Mamakeesick M et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis 2005;178:319-25.
20. Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke 2004;35:649-53.
21. Pollex RL,Hegele R. Genetic determinants of carotid ultrasound traits. Curr Atheroscler Rep 2006;8:206-15.
22. Widder B, Paulat K, Hachpacher J, Hamann H, Hutschenreiter S, Kreutzer C et al. Morphological characterization of carotid artery stenosis by ultrasound duplex scanning. Ultrasound Med Biol 1990;16:349-54.
23. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33.
24. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR et al. Apolipoprotein A-1 and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study Circulation 1996;94:273-8.
25. Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I et al. Apolipoprotein versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003;361:777-80.
26. Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H et al. Thrombogenic factors and recurrent coronary events. Circulation 1999;99:2517-22.
27. Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apoB and triglyceride levels as a useful predictor of coronary heart disease risk in middle- aged UK men. Arterioscler Thromb Vasc Biol 2002; 22:1918-23.
28. Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland E, Njolstad I et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression. A follow-up study of 1952 persons with carotid atherosclerosis The Tromso Study. Circulation 2005;112: 498-504.
29. Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. J Intern Med 2006;259:455-61.
30. Marcovina S, Packard CJ. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 2006;259:437-46.